Correction for: PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer

Zhixuan Ren¹, Li Wang², Chaohui Leng³

¹Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai 200433, P.R. China
²Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, P.R. China
³Department of Oncology, Jiujiang University Affiliated Hospital, Jiujiang 332000, P.R. China

* Equal contribution

Received: November 24, 2024Accepted: December 1, 2024Published: December 31, 2024

https://doi.org/10.18632/aging.206186

Copyright: © 2024 Ren et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.